Arca
Skip to content
Tools
Tools

PLA2G10: Group 10 secretory phospholipase A2

Secretory calcium-dependent phospholipase A2 that primarily targets extracellular phospholipids.

  • Drugs that act on it: 1
  • Approved: 0
  • In phases 1 to 3: 1
  • Sponsors: 1

Who is on it, and how far along

Every drug ChEMBL records acting on PLA2G10, by the furthest stage it has reached for any use, coloured by modality.

How to read this

Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.

  • Small molecule 1

Approved0

    Phase 31

    • Varespladib methyl

    Phase 20

      Phase 10

        The landscape

        Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials.
        DrugFurthest stageSponsorModalityActionOpen trials
        Varespladib methylPhase 3Anthera PharmaceuticalsSmall moleculeInhibitorGroup X secretory phospholipase A2 inhibitor0

        Diseases most associated with it

        Open Targets association score, 0 to 1; all associations
        • Neurodegenerative disease0.49
        • Hypertensive disorder0.14
        • Response to xenobiotic stimulus0.14
        • Type 2 diabetes mellitus0.12
        • Coronary artery disorder0.11
        • Early-onset non-syndromic cataract0.10
        • Early-onset zonular cataract0.09
        • Early-onset posterior polar cataract0.09

        Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL4342, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-21. Gene name, function (UniProt O15496, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets

        Esc

        Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

        Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.